(Reuters) – Biotech firm Prothena Corp is preparing for a potential sale, Bloomberg News reported on Monday, citing people with knowledge of the matter.
The Dublin, Ireland-based drugmaker has been speaking to advisers as it prepares to explore options that may include a sale or partnership, the report said.
Prothena did not immediately respond to a Reuters request for comment.
Shares of the company were up 24% at $54.71.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
